Monitoring Healthcare Algorithms for Racial, Ethnic Disparities
Use of healthcare algorithms can mitigate, exacerbate, or not impact racial and ethnic disparities, according to a literature review published in Annals of Internal Medicine.
Use of healthcare algorithms can mitigate, exacerbate, or not impact racial and ethnic disparities, according to a literature review published in Annals of Internal Medicine.
Over the last decades, air pollution emissions have decreased substantially; however, the magnitude of the change varies by demographics, according to a new study.
Despite advancements, a Michigan Medicine study finds that the death rate for pulmonary embolism remains high and unchanged in recent years—more often killing men, Black patients, and those from rural areas.
Researchers from University of Houston’s RESTORE Lab are collaborating on the development of a mobile intervention for Black smokers with HIV.
Read MoreModerate levels of two outdoor air pollutants, ozone and fine particulate matter, are associated with non-viral asthma attacks in children and adolescents who live in low-income urban areas.
Read MoreRural COPD patients face higher death rates; the first step to helping these patients is understanding why these disparities exist.
Read MoreThe FDA has launched a campaign to educate American Indian/Alaska Native youth ages 12-17 about the harms of e-cigarettes and vaping.
Read MoreNew information has surfaced on the link between the pandemic and the deceleration in progress to reduce smoking in certain populations.
Read MoreA new NIH study found that non-Hispanic Black individuals in four US states experienced a 38% increase in the rate of opioid overdose deaths from 2018 to 2019, while the rates for other race and ethnicity groups held steady or decreased.
Read MoreDespite women’s increased vulnerability and susceptibility to COPD, cases of COPD in women often go misdiagnosed or unidentified in the earlier stages of the disease.
Read MoreA new study reports on how patients’ ethnicities can affect their response to certain pharmaceuticals, which can have an important effect on the results and success of clinical trials.
Read MoreAs part of COPD Awareness Month in November, the CHEST Foundation and Sunovion Pharmaceuticals are encouraging Hispanics to learn more about COPD, and if they are at risk, to get tested.
Read More“Tome Un Respiro” is a Spanish-language campaign to raise awareness among Hispanics in the US about the prevalence, treatment options, and disease management of COPD.
Read MoreIn the last 30 years, COPD has become more prevalent in American women, who now make up more than half of patients currently diagnosed—an estimated 7 million women, in all.
Read MoreSystemic and clinical pulmonary-only sarcoidosis may be caused by different environmental exposures that ultimately lead to these different subsets of the same disease.
Read More